Nannovaccine for Eliciting 10E8-like bnAbs against HIV-1
Award Notice Posted
- Solicitation number
- PHS2021-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Neovaxsyn Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93021C00026 Federal contract award
- Place of performance
- Ames, Iowa 50014, United States
Notice details come from SAM.gov. Updated .
About this opportunity
NeoVaxSyn Inc. was awarded a firm fixed price contract valued at $300,000 by the National Institute of Allergy and Infectious Diseases to develop a nannovaccine aimed at eliciting 10E8-like broadly neutralizing antibodies against HIV-1. Awarded on September 23, 2021 under contract number 75N93021C00026, this small business set-aside contract from the Department of Health and Human Services seeks to advance efforts against HIV/AIDS through neutralizing over 90% of circulating HIV strains worldwide.
Notice text
Awarded contract 75N93021C00026 to NeoVaxSyn Inc for 300000.00 on 2021-07-01.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity